This week, our conversations are with Steve Perrin, president and CSO of Eledon Pharmaceuticals, and Jason Bock, CEO and co-founder of CTMC.

Times:

03:18 CTMC

35:46 Eledon Pharmaceuticals

CTMC

CTMC is a joint venture between Resilience and the MD Anderson Cancer Center. It works like an internal manufacturing group, adapting to change in real time without charge ups and allowing for better control as a company develops their research process. With all of the resources in one circular supply chain (patients, clinicians, manufacturing, and regulatory), CTMC is executing the manufacturing and analytical processes while also supporting active engagement with MD Anderson, preparing to launch trials as soon as the FDA approves an IND. ...